Aprogen Biologics Inc. (KRX:003060)

South Korea flag South Korea · Delayed Price · Currency is KRW
540.00
-23.00 (-4.09%)
At close: Jan 30, 2026
-29.96%
Market Cap106.69B -17.1%
Revenue (ttm)74.91B +10.1%
Net Income-194.29B
EPS-983.23
Shares Out197.57M
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume549,400
Average Volume631,664
Open563.00
Previous Close563.00
Day's Range535.00 - 563.00
52-Week Range460.00 - 887.00
Beta-0.11
RSI54.20
Earnings DateMar 16, 2026

About Aprogen Biologics

Aprogen Biologics Inc. manufactures and sells pharmaceutical products primarily in South Korea. The company was founded in 1960 and is headquartered in Seoul, South Korea. [Read more]

Sector Healthcare
Founded 1960
Employees 391
Stock Exchange Korea Stock Exchange
Ticker Symbol 003060
Full Company Profile

Financial Performance

In 2024, Aprogen Biologics's revenue was 67.38 billion, a decrease of -22.88% compared to the previous year's 87.36 billion. Losses were -104.98 billion, -11.24% less than in 2023.

Financial Statements